Skip to main content
. Author manuscript; available in PMC: 2021 May 2.
Published in final edited form as: Crit Rev Clin Lab Sci. 2019 Nov 2;57(3):161–180. doi: 10.1080/10408363.2019.1678568

Table 2:

Cytochrome P-450 (CYPs) and drug metabolism

Gene Role Drug(s) Affected
CYP2D6 Metabolism of 25% of all drugs Antidepressants, antipsychotics, beta blockers, opioids
CYP2C9 Metabolism of 10% of all drugs Warfarin, NSAIDs, sulfonylureas, phenytoin
CYP2C19 Metabolism of 10–15% of all drugs Clopidogrel, proton pump inhibitors, citalopram, diazepam
CYP1A2 Metabolism of 9% of all drugs Clozapine, olanzapine, theophylline, caffeine
CYP3A4/3A5 Metabolism of 50% of all drugs Statins, benzodiazepenes, antibiotics, antipsychotics
SLC6A4 Serotonin transporter SSRIs
OPRM1 Mu opioid receptor Hydromorphone, morphine, oxymorphone, other opioid agonists
VKORC1 Vitamin K clotting cascade Warfarin (sensitivity)
SLCO1B1 Transport of statins in liver Statins
Factor V (Leiden) Clotting factor V Oral contraceptives
COMT Dopamine and norepinephrine degradation Stimulatory therapies